Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1985 2
1987 2
1990 1
1993 1
1994 2
1996 1
1998 7
1999 1
2000 1
2001 5
2002 6
2003 4
2004 3
2005 1
2006 4
2007 5
2008 7
2009 5
2010 10
2011 11
2012 14
2013 13
2014 16
2015 18
2016 9
2017 15
2018 25
2019 22
2020 21
2021 18
2022 17
2023 24
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Current treatment and recent progress in gastric cancer.
Joshi SS, Badgwell BD. Joshi SS, et al. CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16. CA Cancer J Clin. 2021. PMID: 33592120 Free PMC article. Review.
Biological differences between tumors from Eastern and Western countries add to the complexity of identifying standard-of-care therapy based on international trials. Systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy all have pr …
Biological differences between tumors from Eastern and Western countries add to the complexity of identifying standard-of-care the …
Gastric cancer: a comprehensive review of current and future treatment strategies.
Sexton RE, Al Hallak MN, Diab M, Azmi AS. Sexton RE, et al. Cancer Metastasis Rev. 2020 Dec;39(4):1179-1203. doi: 10.1007/s10555-020-09925-3. Epub 2020 Sep 7. Cancer Metastasis Rev. 2020. PMID: 32894370 Free PMC article. Review.
Strategies are being pursued to prevent gastric cancer development such as H. pylori eradication, which has helped to prevent significant proportion of gastric cancer. ...These figures indicate the need for more effective molecularly driven treatment strategies. Thi …
Strategies are being pursued to prevent gastric cancer development such as H. pylori eradication, which has helped to prevent signifi …
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau JM, Barros R, Fléjou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M. Pimentel-Nunes P, et al. Endoscopy. 2019 Apr;51(4):365-388. doi: 10.1055/a-0859-1883. Epub 2019 Mar 6. Endoscopy. 2019. PMID: 30841008 Free article.
Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscores the importance of diagnosis and risk stratification for these patients. ...H. pylori eradication is also recommended for patients with neo …
Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscore …
Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment.
Norwood DA, Montalvan-Sanchez E, Dominguez RL, Morgan DR. Norwood DA, et al. Gastroenterol Clin North Am. 2022 Sep;51(3):501-518. doi: 10.1016/j.gtc.2022.05.001. Gastroenterol Clin North Am. 2022. PMID: 36153107 Review.
Gastric adenocarcinoma (GC) is the fourth leading cause of global cancer mortality, and the leading infection-associated cancer. ...Upper endoscopy is the gold standard for GC diagnosis, and image-enhanced endoscopy increases the detection of gastric premalig …
Gastric adenocarcinoma (GC) is the fourth leading cause of global cancer mortality, and the leading infection-associated cance …
Management of Gastric Adenocarcinoma for General Surgeons.
Hoshi H. Hoshi H. Surg Clin North Am. 2020 Jun;100(3):523-534. doi: 10.1016/j.suc.2020.02.004. Epub 2020 Mar 18. Surg Clin North Am. 2020. PMID: 32402298 Review.
Gastric cancer is one of the most common cancers in the world, despite declining incidence of the disease in the United States. ...This article reviews pearls and pitfalls of multidisciplinary management of the gastric adenocarcinoma for best outcomes....
Gastric cancer is one of the most common cancers in the world, despite declining incidence of the disease in the United States. ...Th …
Updates on Management of Gastric Cancer.
Johnston FM, Beckman M. Johnston FM, et al. Curr Oncol Rep. 2019 Jun 24;21(8):67. doi: 10.1007/s11912-019-0820-4. Curr Oncol Rep. 2019. PMID: 31236716 Review.
PURPOSE OF REVIEW: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. ...RECENT FINDINGS: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherap …
PURPOSE OF REVIEW: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. ...RECENT FINDI …
Treatment of gastric adenocarcinoma: A rapidly evolving landscape.
Taieb J, Bennouna J, Penault-Llorca F, Basile D, Samalin E, Zaanan A. Taieb J, et al. Eur J Cancer. 2023 Dec;195:113370. doi: 10.1016/j.ejca.2023.113370. Epub 2023 Oct 17. Eur J Cancer. 2023. PMID: 37948843 Free article. Review.
Gastric adenocarcinoma (GC) and gastroesophageal junction adenocarcinoma represent frequent and severe diseases whose management has radically changed over the last 10 years. With the advent of second- and third-line standard therapies for metastatic G …
Gastric adenocarcinoma (GC) and gastroesophageal junction adenocarcinoma represent frequent and severe diseases whose m …
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. Banks M, et al. Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5. Gut. 2019. PMID: 31278206 Free PMC article.
Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. ...The stages in the progression to cancer include chronic gastritis, gastric atrophy (GA), gastric intestinal metaplasia (GIM) and dysplasia. ...
Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. ...The stages in the progression …
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, Malowany AB, Bhadkamkar NA, Deighton DC, Janjigian Y, Karippot A, Khan U, King DA, Klute K, Lacy J, Lee JJ, Mehta R, Mukherjee S, Nagarajan A, Park H, Saeed A, Semrad TJ, Shitara K, Smyth E, Uboha NV, Vincelli M, Wainberg Z, Rajdev L. Shah MA, et al. J Clin Oncol. 2023 Mar 1;41(7):1470-1491. doi: 10.1200/JCO.22.02331. Epub 2023 Jan 5. J Clin Oncol. 2023. PMID: 36603169
RECOMMENDATIONS: For human epidermal growth factor receptor 2 (HER2)-negative patients with gastric adenocarcinoma (AC) and programmed death-ligand 1 (PD-L1) combined positive score (CPS) 5, first-line therapy with nivolumab and chemotherapy (CT) is recommend …
RECOMMENDATIONS: For human epidermal growth factor receptor 2 (HER2)-negative patients with gastric adenocarcinoma (AC) and pr …
American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations.
ASGE standards of practice committee; Forbes N, Elhanafi SE, Al-Haddad MA, Thosani NC, Draganov PV, Othman MO, Ceppa EP, Kaul V, Feely MM, Sahin I, Buxbaum JL, Calderwood AH, Chalhoub JM, Coelho-Prabhu N, Desai M, Fujii-Lau LL, Kohli DR, Kwon RS, Machicado JD, Marya NB, Pawa S, Ruan W, Sheth SG, Storm AC, Thiruvengadam NR, Qumseya BJ; (ASGE Standards of Practice Committee Chair). ASGE standards of practice committee, et al. Gastrointest Endosc. 2023 Sep;98(3):271-284. doi: 10.1016/j.gie.2023.03.015. Epub 2023 Jul 25. Gastrointest Endosc. 2023. PMID: 37498266
This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based summary and recommendations regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. I …
This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based summary and reco …
267 results